Tag Archives: age-related macular degeneration

Sophie J. Bakri, M.D., with the Department of Ophthalmology at Mayo Clinic in Rochester, Minn., and study principal investigator at Mayo Clinic, discusses first-year results from the National Eye Institute–funded study of neovascular age-related macular degeneration (AMD). Findings indicate that bevacizumab … Continue reading →